VANI
Vivani Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.49
+7.19%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -6.2%
- EBIT
- -1.6%
- EPS
- +22.2%
- Free cash flow
- -14.5%
- Operating cash flow
- -11.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +12.4%
Three-year CAGR
- Revenue
- —
- EBITDA
- -13.4%
- EBIT
- -11.7%
- Net income
- -13.3%
- EPS
- +0.0%
- Free cash flow
- -19.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026